Get started
Author

Marjolein Y.V. Homs

Observed names: Homs, Marjolein Y., Homs, Marjolein Y. V., M HOMS, M Y Homs, M Y V Homs, M. Homs, M. Y. Homs, M. Y. V. Homs, M.Y. Homs, M.Y.V. Homs, MY V Homs, Marjolein Y.V. Homs, Marjolein Homs, Marjolein Y V Homs, Marjolein Y. Homs, Marjolein Y. V. Homs, Marjolein Y.V Homs, Marjolein YV Homs
Observed institutions: University Medical Center Groningen, Oregon Health & Science University, Leiden University Medical Center, Erasmus MC, Amsterdam UMC Location University of Amsterdam, University Medical Center Utrecht, Sint Franciscus Gasthuis, Ikazia Ziekenhuis, Erasmus MC Cancer Institute, Amsterdam University Medical Centers, Rijnstate Hospital, Cancer Center Amsterdam, Academisch Ziekenhuis Rotterdam, Daniel den Hoed Kliniek, University of Amsterdam, Amsterdam UMC Location Vrije Universiteit Amsterdam, Erasmus University Rotterdam
ORCID: 0000-0001-9828-2541
Observed ORCID: 0000-0001-9828-2541
OpenAlex ID: A5078260564
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
2020 · Eva Versteijne, Mustafa Suker, et al. · Journal of Clinical Oncology · 1,083
PDF
Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial
2004 · Marjolein YV Homs, Ewout W Steyerberg, et al. · The Lancet · 507
Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis
2019 · Quisette P Janssen, Stefan Buettner, et al. · JNCI Journal of the National Cancer Institute · 297
PDF
A comparison of 3 types of covered metal stents for the palliation of patients with dysphagia caused by esophagogastric carcinoma: A prospective, randomized study
2001 · P SIERSEMA, W HOP, et al. · Gastrointestinal Endoscopy · 234
Neoadjuvant therapy or upfront surgery for resectable and borderline resectable pancreatic cancer: A meta-analysis of randomised controlled trials
2021 · Jacob L. van Dam, Quisette P. Janssen, et al. · European Journal of Cancer · 233
Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protocol for a nationwide multicenter randomized controlled trial
2021 · for the Dutch Pancreatic Cancer Group, Q. P. Janssen, et al. · BMC Cancer · 169
PDF
Use of Large-Diameter Metallic Stents to Seal Traumatic Nonmalignant Perforations of the Esophagus
2003 · Peter D. Siersema, Marjolein Y.V. Homs, et al. · Gastrointestinal Endoscopy · 159
A new esophageal stent design (Niti-S stent) for the prevention of migration: a prospective study in 42 patients
2006 · Els M.L. Verschuur, Marjolein Y.V. Homs, et al. · Gastrointestinal Endoscopy · 138
Causes and Treatment of Recurrent Dysphagia after Self-Expanding Metal Stent Placement for Palliation of Esophageal Carcinoma
2004 · M. Homs, E. Steyerberg, et al. · Endoscopy · 120
The risk of not receiving adjuvant chemotherapy after resection of pancreatic ductal adenocarcinoma: a nationwide analysis
2019 · Tara M. Mackay, F. Jasmijn Smits, et al. · HPB · 118
PDF
Quality of life after palliative treatment for oesophageal carcinoma – a prospective comparison between stent placement and single dose brachytherapy
2004 · Marjolein Y.V Homs, Marie-Louise Essink-Bot, et al. · European Journal of Cancer · 118
Esophageal stents with antireflux valve for tumors of the distal esophagus and gastric cardia: a randomized trial
2004 · Marjolein Y.V. Homs, Peter J. Wahab, et al. · Gastrointestinal Endoscopy · 115
Prior radiation and/or chemotherapy has no effect on the outcome of metal stent placement for oesophagogastric carcinoma
2004 · Marjolein YV Homs, Bettina E Hansen, et al. · European Journal of Gastroenterology & Hepatology · 97
Stent placement or brachytherapy for palliation of dysphagia from esophageal cancer: a prognostic model to guide treatment selection
2005 · Ewout W. Steyerberg, Marjolein Y.V. Homs, et al. · Gastrointestinal Endoscopy · 90
Conditional Survival After Resection for Pancreatic Cancer: A Population-Based Study and Prediction Model
2020 · for the Dutch Pancreatic Cancer Group, Anouk E. J. Latenstein, et al. · Annals of Surgical Oncology · 70
PDF
Chemotherapy for metastatic carcinoma of the esophagus and gastro-esophageal junction
2006 · Marjolein Y.V. Homs, Ate v.d. Gaast, et al. · Cochrane Database of Systematic Reviews · 66
Perioperative or adjuvant mFOLFIRINOX for resectable pancreatic cancer (PREOPANC-3): study protocol for a multicenter randomized controlled trial
2023 · J. L. van Dam, E. M. M. Verkolf, et al. · BMC Cancer · 62
PDF
Adjuvant hepatic arterial infusion pump chemotherapy and resection versus resection alone in patients with low-risk resectable colorectal liver metastases – the multicenter randomized controlled PUMP trial
2019 · F. E. Buisman, M. Y. V. Homs, et al. · BMC Cancer · 59
PDF
The burden of upper gastrointestinal endoscopy in patients with Barrett’s esophagus
2006 · M. Kruijshaar, M. Kerkhof, et al. · Endoscopy · 59
Neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy in resectable and borderline resectable pancreatic cancer (PREOPANC-2): a multicentre, open-label, phase 3 randomised trial
2025 · Quisette P Janssen, Jacob L van Dam, et al. · The Lancet Oncology · 57
High dose rate brachytherapy for the palliation of malignant dysphagia
2003 · Marjolein Y.V. Homs, Wilhelmina M.H. Eijkenboom, et al. · Radiotherapy and Oncology · 56
Neoadjuvant FOLFIRINOX in patients with (borderline) resectable pancreatic cancer: A systematic review and patient-level meta-analysis.
2018 · Quisette Janssen, Stefan Buettner, et al. · Journal of Clinical Oncology · 51
Palliative therapy
2005 · Marjolein Y.V. Homs, Ernst J. Kuipers, et al. · Journal of Surgical Oncology · 51
Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis
2022 · Jessica J. Holster, Marouan El Hassnaoui, et al. · Annals of Surgical Oncology · 46
PDF
Sex, Gender and Age Differences in Treatment Allocation and Survival of Patients With Metastatic Pancreatic Cancer: A Nationwide Study
2022 · Esther N. Pijnappel, Melinda Schuurman, et al. · Frontiers in Oncology · 42
PDF
Works count: 168
Citation count: 5,146
H-index: 32
I10-index: 67
Year
Topic
Type